Hospital Acquired Infection Control Market Expected to be Valued US$ 10.1 Billion by the end of 2033, By Persistence Market Research New York, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Hospital Acquired Infection Control Market: A Comprehensive Report Hospital Acquired Infections (HAIs) are infections acquired by patients during their...

Infection Control Surveillance Solutions Market to hit USD 1.7 Billion by 2030, says Global Market Insights Inc. Selbyville, Delaware, Sept. 19, 2022 (GLOBE NEWSWIRE) -- The infection control surveillance solutions market value is poised to surpass USD 1.7 million by 2030, according to a new research report...

Sepsis Diagnostics Market Worth $1,226.52 Million, Globally, by 2028 at 9.2% CAGR - Exclusive Report by The Insight Partners New York, May 13, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Sepsis Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product...

Phoenix Based BioNovelus Announces a New Product for the Health Disinfectant Industry Phoenix, June 22, 2017 (GLOBE NEWSWIRE) -- / At the recent ExpoMed Show in Mexico City, BioNovelus (ONOV) Chairman and founder, Jean Ekobo, was proud to introduce the newest addition to the...

Melinta Therapeutics and Hartford Hospital Demonstrate Delafloxacin's Potent In-Vitro Activity against Complicated Urinary Tract Infection Pathogens NEW HAVEN, Conn, Sept. 6, 2014 (GLOBE NEWSWIRE) -- Melinta Therapeutics and Hartford Hospital today announced in vitro results from an investigator-sponsored study that highlight delafloxacin's...